Breaking News
Get 55% Off 0
Get Premium Data for Cyber Monday: Up to 55% Off InvestingPro
CLAIM SALE
Close

Moderna Inc (MRNA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Moderna's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
44.44 +1.50    +3.49%
- Closed. Currency in USD
After Hours
44.38
-0.09
-0.20%
- Real-time Data
  • Volume: 8,742,718
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 43.16 - 46.62
Type:  Equity
Market:  United States
Moderna 44.44 +1.50 +3.49%

Moderna (NASDAQ:MRNA) Annual Report

 
This summary provides an overview of the most significant critical numbers from each of the Moderna financial reports, including the Moderna Inc income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the NASDAQ:MRNA financials over time via breakdowns of their annual reports. Advanced annual reports and additional financial summaries (including visual charts) are available to users with an InvestingPro account.

Moderna, Inc. reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, the company reported revenue was USD 1,862 million compared to USD 1,831 million a year ago. Net income was USD 13 million compared to net loss of USD 3,630 million a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to basic loss per share from continuing operations of USD 9.53 a year ago. Diluted earnings per share from continuing operations was USD 0.03 compared to diluted loss per share from continuing operations of USD 9.53 a year ago. For the nine months, revenue was USD 2,270 million compared to USD 4,037 million a year ago. Net loss was USD 2,441 million compared to USD 4,931 million a year ago. Basic loss per share from continuing operations was USD 6.37 compared to USD 12.89 a year ago. Diluted loss per share from continuing operations was USD 6.37 compared to USD 12.89 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

%SHORT_NAME% (MRNA) Income Statement & Profits

Gross margin TTM -27.55%
Operating margin TTM -53%
Net Profit margin TTM -43.77%
Return on Investment TTM -16.43%
 Total Revenue  Net Income
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Revenue 1862 241 167 2811
Gross Profit 211 -1095 -992 476
Operating Income -70 -1363 -1266 6
Net Income 13 -1279 -1175 217

MRNA Annual Report (Balance Sheet)

Quick Ratio MRQ 3.83
Current Ratio MRQ 4.39
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 11.36%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Assets 15803 15680 16729 18426
Total Liabilities 3876 3968 3912 4572
Total Equity 11927 11712 12817 13854

%SHORT_NAME% (MRNA) Latest Cash Flow Statement

Cash Flow/Share TTM -8.34
Revenue/Share TTM 13.22
Operating Cash Flow  -71.15%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -1566 -1274 -989 622
Cash From Investing Activities 721 1649 118 -538
Cash From Financing Activities 11 34 14 -109
Net Change in Cash -833 409 -857 -25
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Moderna (MRNA) Price Discussion

Write your thoughts about Moderna Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rehan Khan
Rehan Khan Nov 15, 2024 18:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
At 37. Moderna is very cheap
Roy Bhika
Roy Bhika Nov 08, 2024 19:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Whats going on with this stock
John Williams
John Williams Oct 02, 2024 22:16
Saved. See Saved Items.
This comment has already been saved in your Saved Items
As I predicted last November - $60s. Well done me.
johny sheikh
johny sheikh May 02, 2024 12:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Next 135?
John Williams
John Williams Nov 02, 2023 11:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$69.50…
Ken Laing
Ken Laing Oct 26, 2023 5:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
At some point this will be a buy
John Williams
John Williams Oct 17, 2023 17:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hype stock. Trading pharma stocks is tedious at best, in this case, unrewarding too. I wouldn’t bother unless I heard news of a serious covid strain - the kind that sends crude oil down at least 10-15%.
Ferdinand Peelen
Ferdinand Peelen Aug 17, 2023 15:40
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What's up with Moderna today?
John Williams
John Williams Aug 07, 2023 16:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Told ya.
John Williams
John Williams Mar 30, 2023 21:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sc mortgage should dump this
Al Al
Al Al Mar 30, 2023 21:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They have high conviction in this, they believe it offers the best growth story and new drugs in the works.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email